These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7160017)

  • 1. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3719-27. PubMed ID: 7160017
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin.
    Juni K; Ogata J; Nakano M; Ichihara T; Mori K; Akagi M
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):313-8. PubMed ID: 4006022
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3363-8. PubMed ID: 7337936
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2621-8. PubMed ID: 7139823
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and evaluation in vitro and in vivo of polycarbonate microspheres containing dibucaine.
    Kojima T; Nakano M; Juni K; Inoue S; Yoshida Y
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5119-25. PubMed ID: 3830439
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of release rate of bleomycin from polylactic acid microspheres by additives.
    Juni K; Ogata J; Matsui N; Kubota M; Nakano M
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1609-14. PubMed ID: 2412716
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives.
    Juni K; Ogata J; Matsui N; Kubota M; Nakano M
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1734-8. PubMed ID: 3862466
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.
    Bodmeier R; McGinity JW
    J Microencapsul; 1988; 5(4):325-30. PubMed ID: 3236152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of sustained release microspheres containing extracts from Caulis sinomenii with polylactic acid and their release property in vitro].
    Zhan W; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2142-5. PubMed ID: 21046749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.
    Bodmeier R; McGinity JW
    J Microencapsul; 1987; 4(4):279-88. PubMed ID: 3504509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres.
    Bodmeier R; McGinity JW
    J Microencapsul; 1987; 4(4):289-97. PubMed ID: 3504510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on preparation process of artesunate polylactic acid microspheres].
    Pan XW; Wang W; Fang HY; Wang FG; Cai ZB
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4071-5. PubMed ID: 24791491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride.
    Ichihara T; Sakamoto K; Mori K; Akagi M
    Cancer Res; 1989 Aug; 49(15):4357-62. PubMed ID: 2472878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcatheter hepatic arterial embolization therapy using degradable polylactic acid microspheres].
    Ichihara T; Akagi M; Mori K; Ikei S; Sakamoto K; Katauchi S; Beppu T; Nokano M; Tuni K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1944-5. PubMed ID: 2996441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of the local anesthetic effect of tetracaine hydrochloride solutions and tetracaine in microspheres.
    Wakiyama N; Juni K; Nakano M
    J Pharmacobiodyn; 1982 Jan; 5(1):13-7. PubMed ID: 7077517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 Apr; 44(4):276-9. PubMed ID: 2772002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(lactic acid) microspheres as immunological adjuvants for orally delivered cholera toxin b subunit.
    Almeida AJ; Alpar HO; Williamson D; Brown MR
    Biochem Soc Trans; 1992 Nov; 20(4):316S. PubMed ID: 1486986
    [No Abstract]   [Full Text] [Related]  

  • 19. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid].
    Tokuda K; Natsugoe S; Kumanohoso T; Shimada M; Yoshizawa H; Hatate Y; Nakamura K; Yamada K; Nedachi M; Aiko T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1641-3. PubMed ID: 7574782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.